Stay updated with breaking news from Nasdaq Cnta. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report) have been assigned an average rating of “Moderate Buy” from the seven research firms that are currently covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. […]
BOSTON and LONDON, April 23, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that...
Centessa Pharmaceuticals (NASDAQ:CNTA – Get Free Report) and Larimar Therapeutics (NASDAQ:LRMR – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership. Insider and Institutional Ownership 82.0% of Centessa […]
BMO Capital Markets reissued their outperform rating on shares of Centessa Pharmaceuticals (NASDAQ:CNTA – Free Report) in a research report report published on Monday morning, Benzinga reports. BMO Capital Markets currently has a $15.00 price objective on the stock. Centessa Pharmaceuticals Stock Performance Shares of CNTA stock opened at $10.37 on Monday. The business has […]
Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report) dropped 5.6% during trading on Monday . The company traded as low as $11.48 and last traded at $11.52. Approximately 351,020 shares were traded during trading, a decline of 16% from the average daily volume of 419,941 shares. The stock had previously closed at $12.20. Centessa Pharmaceuticals […]